181 related articles for article (PubMed ID: 35382109)
1. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.
Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP
Drugs Context; 2022; 11():. PubMed ID: 35382109
[TBL] [Abstract][Full Text] [Related]
2. Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection.
Hayes K; Panaccio MP; Houston P; Niewoehner J; Fahim M; Wan GJ; Dhillon B
Open Access Rheumatol; 2021; 13():315-323. PubMed ID: 34703332
[TBL] [Abstract][Full Text] [Related]
3. Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis.
Hayes K; Panaccio MP; Goel N; Fahim M
Rheumatol Ther; 2021 Mar; 8(1):327-346. PubMed ID: 33400194
[TBL] [Abstract][Full Text] [Related]
4. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis.
Fleischmann R; Furst DE
Expert Opin Drug Saf; 2020 Aug; 19(8):935-944. PubMed ID: 32497440
[TBL] [Abstract][Full Text] [Related]
5. Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis.
Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio M; Karlsson D; Furst DE
Rheumatol Ther; 2022 Apr; 9(2):649-661. PubMed ID: 35184268
[TBL] [Abstract][Full Text] [Related]
6. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
[TBL] [Abstract][Full Text] [Related]
7. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
8. Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action.
Gillis T; Crane M; Hinkle C; Wei N
Open Access Rheumatol; 2017; 9():131-138. PubMed ID: 28790870
[TBL] [Abstract][Full Text] [Related]
9. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
Askanase AD; Furie RA
Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860
[TBL] [Abstract][Full Text] [Related]
10. Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis.
Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio MP; Karlsson D; Furst DE
Rheumatol Ther; 2022 Apr; 9(2):435-446. PubMed ID: 34919213
[TBL] [Abstract][Full Text] [Related]
11. Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial.
Fleischmann R; Furst DE; Connolly-Strong E; Liu J; Zhu J; Brasington R
Rheumatol Ther; 2020 Jun; 7(2):327-344. PubMed ID: 32185745
[TBL] [Abstract][Full Text] [Related]
12. Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis.
Ho-Mahler N; Turner B; Eaddy M; Hanke ML; Nelson WW
Open Access Rheumatol; 2020; 12():21-28. PubMed ID: 32110122
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Philbin M; Niewoehner J; Wan GJ
Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
[TBL] [Abstract][Full Text] [Related]
14. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
Wan GJ; Niewoehner J; Hayes K
Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States.
Nelson WW; Philbin MJ; Gallagher JR; Heap K; Carroll S; Wan GJ
Rheumatol Ther; 2017 Dec; 4(2):465-474. PubMed ID: 29071588
[TBL] [Abstract][Full Text] [Related]
16. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis.
Bindra J; Chopra I; Niewoehner J; Panaccio M; Wan GJ
Clinicoecon Outcomes Res; 2021; 13():349-358. PubMed ID: 33986603
[TBL] [Abstract][Full Text] [Related]
18. Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Askanase AD; Zhao E; Zhu J; Bilyk R; Furie RA
Rheumatol Ther; 2020 Dec; 7(4):893-908. PubMed ID: 32996096
[TBL] [Abstract][Full Text] [Related]
19. Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.
Decker DA; Higgins P; Hayes K; Bollinger C; Becker P; Wright D
BMC Musculoskelet Disord; 2020 Aug; 21(1):586. PubMed ID: 32867752
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
Kaplan J; Miller T; Baker M; Due B; Zhao E
Front Neurol; 2020; 11():598496. PubMed ID: 33414758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
